Articles

Study: Indianapolis high-priced hospital market

Indianapolis-area hospitals have negotiated reimbursement rates with private health insurers that are two and three times higher than those paid by the federal Medicare program, suggesting the hospitals have the upper hand over insurers, according to a new study.

Read More

Q&A

Les Zwirn, executive director of Better Healthcare for Indiana, talked about his group’s progress on promoting community collaborations to improve health and reduce the cost of care in cities around Indiana. BHI is hosting its third health care summit of Indiana community leaders today at Second Presbyterian Church in Indianapolis.

Read More

Q&A: Jim Hamilton

Jim Hamilton, an employee-benefits lawyer at Bose McKinney & Evans in Indianapolis, discussed the likelihood of a Republican-controlled U.S. House of Representatives changing or even outright repealing the health care reform law, formally known as the Patient Protection and Affordable Care Act.

Read More

Health care reform boosts business for consultants

John Gause has grown the size of his benefits brokerage and consulting firm by more than half this year for one big reason: health care reform. He needs more hands on deck because his clients–employers–are facing a raft of new regulations with which they must comply.

Read More

Consultants: Pharma industry facing huge changes

Heitzman_WatchVideoTo date, most analysts say health reform turned out pretty well for the pharmaceutical industry. But a detailed analysis by Deloitte Consulting says the indirect effects of reform will deliver a gut punch to the industry that will lead to full-scale transformation akin to what the telecommunications world has seen over the past three decades.

Read More

Insurers cautious on accountable care

Health insurers, including locally based WellPoint Inc. and Advantage Health Solutions, have been looking to work with health care providers to form accountable-care organizations. But they also worry that the accountable-care concept will become nothing more than a negotiating tactic by hospitals and doctors.

Read More

Drugmakers’ ‘doughnut hole’ deal to shave sales

Drugmakers including Pfizer Inc., AstraZeneca, Bristol-Myers Squibb Co. and Eli Lilly and Co. may provide more than $2 billion in drug discounts to senior citizens next year under a deal pharmaceutical companies made with the White House.

Read More

Rules mostly falling WellPoint’s way

Health insurers won fairly broad leeway under key rules suggested by state insurance commissioners that will govern what kinds of expenses count toward meeting a new federal threshold to spend at least 80 percent of premiums dollars on medical care.

Read More

On-site health care clinics moving beyond traditional settings

Health clinics based in employers’ offices are showing signs of breaking out of their niche among blue collar and government employers—factories, warehouses and school corporations—and could pop up in Class A office buildings filled with white collar workers.

Read More

After health reform, Lilly looking for more

The health reform debate may have ended in Congress, but Eli Lilly and Co. remains active, sponsoring a talk about the positives of the
bill—and calling for further government efforts to help pharmaceutical research and development.

Read More